Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Joe Copia who wrote (24351)	3/24/2002 5:09:39 AM
From: ig	Respond to of 25711

I'll see what I can find on SUGR, Joe, since I made damned near 1000% on SSPC last year in just a few days, after getting in at the open at .05 after reading this: Message 15809212 Thx, ig

To: Joe Copia who wrote (24351)	3/24/2002 6:59:34 AM
From: ig	Read Replies (1) \| Respond to of 25711

Did you know that MTLC board-member Kenneth W. Brimmer is (or was) a member of the board of directors of Sterion Incorporated (STEN)? pinksheets.com (click on top item, the 8-K dated 2/28/2002, then go to Item I, paragraph 3.) Sterion was previously Oxboro Medical (OMED), which eventually acquired Surgidyne (SGDN): biz.yahoo.com Anyway, it caught my eye that Brimmer is on the board of a company (MTLC) that now wants to buy 90% of a company (SUGR, formerly SGDN) that was acquired by another company (STEN, formerly OMED) of which Brimmer is a board member. Does any of this mean anything? I have no idea. Also, here's a paragraph on the OMED-SGDN deal that might be of interest to you: "Oxboro Medical Inc. (Ticker: OMED) of Minneapolis, a developer, manufacturer and marketer of single-use disposable medical supplies and sterilization container systems, says it and Surgidyne Inc. (Ticker: SGDN) have agreed to push back the closing of Oxboro's purchase of Surgidyne's assets until Jan. 15, or such other time as the parties may mutually agree. The closing date was changed to allow Surgidyne adequate time to obtain shareholder approval. Oxboro has agreed to purchase the assets pursuant to a deal dated Oct. 4 in exchange for $200,000 in cash. Minneapolis-based Surgidyne says it will become a publicly-traded shell company after the deal and seek to merge with a private firm." profitsjournal.com Hope some of that helped. If not, well, I tried! :-) ig